Clinical Trial Update: The Impact of Salmeterol-Fluticasone on Sleep in Patients With COPD [NA]

View source ↗

Summary

A clinical trial evaluating the impact of the salmeterol-fluticasone combination on sleep in COPD patients has been withdrawn from the clinical trials registry.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Sleep Disorders

Drugs mentioned

• Advair (fluticasone propionate/salmeterol)

Snippet

Sponsor: Northwestern University | Conditions: Chronic Obstructive Pulmonary Disease, Sleep Disorders | NA | Status: WITHDRAWN